Centogene & C-Path team on LD research and drug development
PremiumThe FlyCentogene & C-Path team on LD research and drug development
5M ago
CENTOGENE Shareholders Approve Key Resolutions
Premium
Company Announcements
CENTOGENE Shareholders Approve Key Resolutions
5M ago
Centogene N.V. Races Against Nasdaq Delisting
Premium
Company Announcements
Centogene N.V. Races Against Nasdaq Delisting
5M ago
Centogene’s Biodatabank Drives Rare Disease Breakthroughs
PremiumCompany AnnouncementsCentogene’s Biodatabank Drives Rare Disease Breakthroughs
6M ago
Centogene Biodatabank grows to incorporate insights from over 850K patients
Premium
The Fly
Centogene Biodatabank grows to incorporate insights from over 850K patients
6M ago
Centogene N.V. Explores Financial Strategies
Premium
Company Announcements
Centogene N.V. Explores Financial Strategies
6M ago
Centogene receives Nasdaq notice of delisting, will request hearing
PremiumThe FlyCentogene receives Nasdaq notice of delisting, will request hearing
9M ago
Centogene to explore a range of strategic alternatives
Premium
The Fly
Centogene to explore a range of strategic alternatives
9M ago
Centogene, The Lab announce rare disease research collaboration
Premium
The Fly
Centogene, The Lab announce rare disease research collaboration
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100